Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.
Social Links